HSCT-induced alterations in DCs to promote IL-17 and lung pathology

HSCT 诱导的 DC 改变促进 IL-17 和肺部病理学改变

基本信息

  • 批准号:
    9276115
  • 负责人:
  • 金额:
    $ 48.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2020-04-30
  • 项目状态:
    已结题

项目摘要

Abstract: Hematopoietic stem cell transplantation (HSCT) is a curative option for the treatment of numerous malignancies and inherited genetic disorders; however, the success of the procedure is hampered by numerous complications. Pulmonary complications cause significant morbidity and mortality following HSCT and most notably include infections, idiopathic pneumonia syndrome (IPS), bronchiolitis obliterans (BOS) and cryptogenic organizing pneumonia (COP). These conditions are characterized by acute and chronic inflammation and can include tissue fibrosis, severely damaging lung function. While more common following allogeneic HSCT, IPS, BOS and COP have also been reported as a complication of autologous HSCT and their diagnosis is defined, in part, by the absence of infection. However, accumulating evidence suggests these lung pathologies could represent immunopathology that develops as a consequence of a previous viral infection, or possibly due to an occult infection. Importantly, herpesviruses were recently identified as the most common occult infection in patients with IPS. We have developed a murine model in which syngeneic bone marrow transplant (BMT) mice that are fully reconstituted with donor-derived cells develop severe lung pathology characterized by interstitial pneumonitis, vasculitis and fibrosis following infection with murine gamma herpesvirus-68 (γHV-68). This lung pathology is well established at 21 days post-infection when lytic viral infection has been cleared and the virus has established latency. Our published and preliminary findings suggest the process of BMT alters the phenotype of lung dendritic cells (DCs). DCs from BMT mice overproduce IL-1β, IL-6, TGFβ and IL-23. These BMT-induced DC alterations lead to the skewing of the CD4 response to a Th17, rather than a Th1 response post-infection with γHV-68. The consequence of this persistent skewing is the development of IL-17-dependent pneumonitis and fibrosis. In addition, we have evidence that adoptive transfer of DCs from infected control mice into BMT mice can restore Th1 cell priming and limit development of lung immunopathology focusing our current studies on trying to understand how the process of BMT impairs the function of lung DCs. Preliminary data suggest that lung DCs in BMT mice are characterized by reduced autophagy and impaired expression of the Notch ligand, delta like ligand 4 (DLL4). Reduced autophagy could explain the overproduction of IL-1β if DCs in BMT mice are unable to clear activated inflammasomes. Notch signaling is highly context-dependent and can both enhance and inhibit T cell signaling. Thus, the overall goal of the proposed research is to mechanistically understand how DCs are altered following HSCT in ways that promote pathologic rather than protective immune responses to respiratory viruses. Most importantly, we will determine whether these molecular alterations that characterize murine DCs post-BMT are also evident in DCs from human patients experiencing lung dysfunction post-HSCT. Our hypothesis is that HSCT results in reduced autophagy and impaired DLL4 expression in lung DCs in response to γHV-68 infection, and that this alteration in DCs promotes pathologic Th17 rather than protective Th1 responses. We will address this hypothesis in the following specific aims. Aim 1) To identify the relevant DC population responsible for priming γHV-68-specific T cell responses and determine whether autophagy is impaired in these DCs post-BMT and γHV-68 infection Aim 2) To determine if BMT DCs are characterized by defective Notch ligand expression or altered costimulatory receptors Aim 3) To determine the translational relevance of these findings by determining whether the responses are specific to γ-herpesviruses, and whether similar DC phenotypes are noted in patients post-HSCT Completion of these specific aims will be significant for several reasons. This work will solidify the critical role that latent or occult infection play in causing “idiopathic” lung pathology post-HSCT and will provide novel information regarding the mechanistic alterations that occur in DCs post-transplant. Most importantly, this work will identify and test strategies to restore DC function post-BMT and will provide translational proof that these phenotypes characterize human DCs post-HSCT.
摘要:造血干细胞移植(HSCT)是治疗许多恶性肿瘤的一种治疗选择

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bethany B. Moore其他文献

The Role of CXC Chemokines in the Regulation of Angiogenesis in Association with Non-Small-Cell Lung Cancer
CXC趋化因子在调节与非小细胞肺癌相关的血管生成中的作用
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Strieter;Christina L. Addison;Bethany B. Moore;D. Arenberg
  • 通讯作者:
    D. Arenberg
Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus at a Glance Commentary
伽玛疱疹病毒引起的小鼠模型中已建立的肺纤维化的恶化概览
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Mcmillan;Bethany B. Moore;Jason B Weinberg;Kevin M. Vannella;W. B. Fields;P. J. Christensen;L. V. van Dyk;G. Toews
  • 通讯作者:
    G. Toews
Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation
Ineffectual AEC2-to-AEC1 Differentiation in IPF: Persistence of KRT8hi Transitional State.
IPF 中 AEC2 到 AEC1 的无效分化:KRT8hi 过渡状态的持续存在。
Dendritic Cell – Fibroblast Crosstalk via TLR9 and AHR Signaling Drives Lung Fibrogenesis
树突状细胞 - 通过 TLR9 和 AHR 信号传导的成纤维细胞串扰驱动肺纤维化
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    H. Carter;Rita Medina Costa;Taylor Sterling Adams;Talon Gilchrist;Claire E. Emch;Monica Bame;J. Oldham;A. Linderholm;I. Noth;Naftali Kaminski;Bethany B. Moore;S. Gurczynski
  • 通讯作者:
    S. Gurczynski

Bethany B. Moore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bethany B. Moore', 18)}}的其他基金

Immunobiology of Lung Injury and Fibrosis
肺损伤和纤维化的免疫生物学
  • 批准号:
    10523118
  • 财政年份:
    2019
  • 资助金额:
    $ 48.51万
  • 项目类别:
Immunobiology of Lung Injury and Fibrosis
肺损伤和纤维化的免疫生物学
  • 批准号:
    10062513
  • 财政年份:
    2019
  • 资助金额:
    $ 48.51万
  • 项目类别:
Immunobiology of Lung Injury and Fibrosis
肺损伤和纤维化的免疫生物学
  • 批准号:
    10307537
  • 财政年份:
    2019
  • 资助金额:
    $ 48.51万
  • 项目类别:
miR-29b and autophagy regulate alveolar macrophage function post-BMT
miR-29b 和自噬调节 BMT 后肺泡巨噬细胞功能
  • 批准号:
    8864133
  • 财政年份:
    2015
  • 资助金额:
    $ 48.51万
  • 项目类别:
miR-29b and autophagy regulate alveolar macrophage function post-BMT
miR-29b 和自噬调节 BMT 后肺泡巨噬细胞功能
  • 批准号:
    9189677
  • 财政年份:
    2015
  • 资助金额:
    $ 48.51万
  • 项目类别:
Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
病毒性细菌性肺炎后:MicroRNA 和自噬的作用
  • 批准号:
    9247795
  • 财政年份:
    2014
  • 资助金额:
    $ 48.51万
  • 项目类别:
Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
病毒性细菌性肺炎后:MicroRNA 和自噬的作用
  • 批准号:
    9038427
  • 财政年份:
    2014
  • 资助金额:
    $ 48.51万
  • 项目类别:
Periostin Regulation of Lung Fibrosis
骨膜素对肺纤维化的调节
  • 批准号:
    8590983
  • 财政年份:
    2013
  • 资助金额:
    $ 48.51万
  • 项目类别:
Periostin Regulation of Lung Fibrosis
骨膜素对肺纤维化的调节
  • 批准号:
    8847377
  • 财政年份:
    2013
  • 资助金额:
    $ 48.51万
  • 项目类别:
Periostin Regulation of Lung Fibrosis
骨膜素对肺纤维化的调节
  • 批准号:
    8704825
  • 财政年份:
    2013
  • 资助金额:
    $ 48.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了